Protalix BioTherapeutics
PLX
#8601
Rank
ยฃ0.18 B
Marketcap
ยฃ2.22
Share price
-5.23%
Change (1 day)
65.87%
Change (1 year)

P/S ratio for Protalix BioTherapeutics (PLX)

P/S ratio as of November 2026 (TTM): 3.10

According to Protalix BioTherapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.50. At the end of 2026 the company had a P/S ratio of 2.30.

P/S ratio history for Protalix BioTherapeutics from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20262.30-13.36%
20252.655.14%
20242.5227.27%
20231.9836.07%
20221.4647.48%
20210.9880-48.65%
20201.92116.21%
20190.8899-1.84%
20180.9065-81.12%
20174.80-19.81%
20165.99
2015N/A-100%
201411.4-64.03%
201331.6124.11%
201214.1-66.53%
201142.1-66.86%
2010127-90.79%
2009> 1000-100%
2008> 1000
2001> 1000

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.47-20.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
4.19 35.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.17 131.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
2.70-12.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel